Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates

Heron Therapeutics (HRTX) Misses Q1 EPS by 15c

May 9, 2022 5:01 PM EDT

Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.63), $0.15 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $22.4 million versus the consensus estimate of $22.61 million.

GUIDANCE:

Heron Therapeutics sees FY2022 revenue of $89-93 million.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

... More